Gene: LYZ

4069
LYZF1|LZM
lysozyme
protein-coding
12q15
Ensembl:ENSG00000090382 MIM:153450 Vega:OTTHUMG00000169342 UniprotKB:P61626
NG_008195.1
PubMed|SNP Mapped
1   ANCO-SNPs
ND|AD
1   
NA (AD)  NA (ND)   (Frontal_Cortex)
3.025e-2 (AD)  5.412e-2 (ND)

ANCO-SNPs

SNP ID Position Alleles Trait Variation Type
rs1800973chr12:69350234 (GRCh38.p7)C>Aalcohol dependenceSNV(Single Nucleotide Variation)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
FCN10.765
VNN20.757
MNDA0.72
PLBD10.711
CST70.707
FCGR3B0.707
CSF3R0.702
IL18RAP0.688
S100A90.679
APOBEC3C0.678

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
MAGIX-0.521
ZNF835-0.481
HAS1-0.48
DLK2-0.468
CORT-0.465
CD3EAP-0.456
LRTM2-0.454
RCOR2-0.45
MYADML2-0.45
BCL11A-0.446

Drugs/Compounds

ID Drug Name Drug Type CAS Num Status Role
DB00128L-Aspartic AcidSmall Molecule56-84-8Approved|NutraceuticalTarget
DB02159(R)-Propylene glycolSmall Molecule4254-14-2ExperimentalTarget
DB027594-Methylumbelliferyl ChitobioseSmall MoleculeExperimentalTarget
DB02772SucroseSmall Molecule57-50-1Approved|Experimental|InvestigationalTarget
DB03006Arsanilic acidSmall Molecule98-50-0ExperimentalTarget
DB03013Di(N-Acetyl-D-Glucosamine)Small MoleculeExperimentalTarget
DB03120Para-Toluene SulfonateSmall MoleculeExperimentalTarget
DB03175Propyl alcoholSmall Molecule71-23-8Approved|ExperimentalTarget
DB03189Cu-CyclamSmall MoleculeExperimentalTarget
DB034873-AminosuccinimideSmall MoleculeExperimentalTarget
DB03967Dodecyl SulfateSmall MoleculeExperimentalTarget
DB04194ChitotrioseSmall MoleculeExperimentalTarget
DB04268Methylumbelliferyl ChitotrioseSmall MoleculeExperimentalTarget
DB06912UNDECA-3,7-DIENE-1,3,7,11-TETRACARBALDEHYDESmall MoleculeExperimentalTarget
ID Drug Name Action PubMed
C0810141,2-bis(2,4,6-tribromophenoxy)ethane"1,2-bis(2,4,6-tribromophenoxy)ethane results in increased expression of LYZ mRNA"28249227
C02598415-hydroxy-5,8,11,13-eicosatetraenoic acid"15-hydroxy-5,8,11,13-eicosatetraenoic acid results in increased secretion of LYZ protein"23355332
C02598415-hydroxy-5,8,11,13-eicosatetraenoic acid"artemisinine inhibits the reaction [15-hydroxy-5,8,11,13-eicosatetraenoic acid results in increased secretion of LYZ protein]"23355332
C02598415-hydroxy-5,8,11,13-eicosatetraenoic acid"IL1B protein affects the reaction [15-hydroxy-5,8,11,13-eicosatetraenoic acid results in increased secretion of LYZ protein]"23355332
C02598415-hydroxy-5,8,11,13-eicosatetraenoic acid"IL1B protein affects the reaction [TNF protein affects the reaction [15-hydroxy-5,8,11,13-eicosatetraenoic acid results in increased secretion of LYZ protein]]"23355332
C02598415-hydroxy-5,8,11,13-eicosatetraenoic acid"[parthenolide co-treated with artemisinine co-treated with Quercetin] inhibits the reaction [15-hydroxy-5,8,11,13-eicosatetraenoic acid results in increased secretion of LYZ protein]"23355332
C02598415-hydroxy-5,8,11,13-eicosatetraenoic acid"parthenolide inhibits the reaction [15-hydroxy-5,8,11,13-eicosatetraenoic acid results in increased secretion of LYZ protein]"23355332
C02598415-hydroxy-5,8,11,13-eicosatetraenoic acid"Quercetin inhibits the reaction [15-hydroxy-5,8,11,13-eicosatetraenoic acid results in increased secretion of LYZ protein]"23355332
C02598415-hydroxy-5,8,11,13-eicosatetraenoic acid"SB 203580 inhibits the reaction [15-hydroxy-5,8,11,13-eicosatetraenoic acid results in increased secretion of LYZ protein]"23355332
C02598415-hydroxy-5,8,11,13-eicosatetraenoic acid"TNF protein affects the reaction [15-hydroxy-5,8,11,13-eicosatetraenoic acid results in increased secretion of LYZ protein]"23355332
C02598415-hydroxy-5,8,11,13-eicosatetraenoic acid"TNF protein affects the reaction [IL1B protein affects the reaction [15-hydroxy-5,8,11,13-eicosatetraenoic acid results in increased secretion of LYZ protein]]"23355332
C1026351-ethyl-2-benzimidazolinone1-ethyl-2-benzimidazolinone affects the secretion of LYZ protein15234967
C0467282,2'-azobis(2-amidinopropane)"2,2'-azobis(2-amidinopropane) results in increased degradation of LYZ protein"11322927
C0467282,2'-azobis(2-amidinopropane)"6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased degradation of LYZ protein]"11322927
C0467282,2'-azobis(2-amidinopropane)"Chlorogenic Acid inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased degradation of LYZ protein]"11322927
C0467282,2'-azobis(2-amidinopropane)"Quercetin inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased degradation of LYZ protein]"11322927
C4829003-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone3-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone inhibits the reaction [Colforsin results in increased secretion of LYZ protein]15234967
C0230353,4,5,3',4'-pentachlorobiphenyl"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of LYZ mRNA"19692669
C0230353,4,5,3',4'-pentachlorobiphenyl"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of LYZ mRNA"20959002
C0106436-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid"6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased degradation of LYZ protein]"11322927
D000082AcetaminophenAcetaminophen results in increased expression of LYZ mRNA26690555
D000535Aluminum[APP protein modified form binds to Aluminum] which results in decreased expression of LYZ mRNA21298039
D000638AmiodaroneAmiodarone results in increased expression of LYZ mRNA19774075
D018501Antirheumatic AgentsAntirheumatic Agents results in decreased expression of LYZ mRNA24449571
D001152ArsenicalsArsenicals results in decreased expression of LYZ mRNA28625800
D001152ArsenicalsArsenicals results in decreased secretion of LYZ protein28625800
C031327artemisinine"artemisinine inhibits the reaction [15-hydroxy-5,8,11,13-eicosatetraenoic acid results in increased secretion of LYZ protein]"23355332
C031327artemisinine"[parthenolide co-treated with artemisinine co-treated with Quercetin] inhibits the reaction [15-hydroxy-5,8,11,13-eicosatetraenoic acid results in increased secretion of LYZ protein]"23355332
D001374AzacitidineAzacitidine results in increased expression of LYZ mRNA19194470
D001379AzathioprineAzathioprine results in decreased expression of LYZ mRNA22623647
C547126AZM551248AZM551248 results in increased expression of LYZ mRNA22323515
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of LYZ mRNA22209252
D001564Benzo(a)pyrene[Benzo(a)pyrene co-treated with sodium bichromate] results in decreased expression of LYZ mRNA21632023
D001564Benzo(a)pyrene[Benzo(a)pyrene co-treated with sodium bichromate] results in increased expression of LYZ mRNA21632023
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of LYZ mRNA28651000
D004958EstradiolEstradiol results in increased expression of LYZ mRNA21715713
D004958Estradiol[Estradiol co-treated with Progesterone] results in decreased expression of LYZ mRNA20660070
C543008bis(4-hydroxyphenyl)sulfone[bis(4-hydroxyphenyl)sulfone co-treated with Pam(3)CSK(4) peptide] results in increased activity of LYZ protein28806546
C543008bis(4-hydroxyphenyl)sulfonebis(4-hydroxyphenyl)sulfone results in increased activity of LYZ protein28806546
C543008bis(4-hydroxyphenyl)sulfonebis(4-hydroxyphenyl)sulfone results in increased expression of LYZ mRNA28806546
C543008bis(4-hydroxyphenyl)sulfone[Pam(3)CSK(4) peptide co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of LYZ mRNA28806546
C543008bis(4-hydroxyphenyl)sulfone[Poly I-C co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of LYZ mRNA28806546
C006780bisphenol A[bisphenol A co-treated with Pam(3)CSK(4) peptide] results in increased activity of LYZ protein28806546
C006780bisphenol Abisphenol A results in increased activity of LYZ protein28806546
C006780bisphenol Abisphenol A results in increased expression of LYZ mRNA28806546
C006780bisphenol A[Pam(3)CSK(4) peptide co-treated with bisphenol A] results in increased expression of LYZ mRNA28806546
C006780bisphenol A[Poly I-C co-treated with bisphenol A] results in increased expression of LYZ mRNA28806546
C006780bisphenol Abisphenol A results in increased expression of LYZ mRNA26364221
D001761BleomycinBleomycin results in decreased expression of LYZ protein25933445
D019256Cadmium ChlorideCadmium Chloride results in decreased expression of LYZ protein24419708
D002217CarbacholCarbachol affects the secretion of LYZ protein15234967
D002251Carbon TetrachlorideCarbon Tetrachloride affects the expression of LYZ mRNA17484886
D002251Carbon TetrachlorideCarbon Tetrachloride results in increased expression of LYZ mRNA16239168
D002726Chlorogenic Acid"Chlorogenic Acid inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased degradation of LYZ protein]"11322927
C074702chromium hexavalent ionchromium hexavalent ion results in decreased activity of LYZ protein21925273
C074702chromium hexavalent ionchromium hexavalent ion results in decreased expression of LYZ mRNA21925273
C074702chromium hexavalent ionchromium hexavalent ion results in decreased secretion of LYZ protein21925273
D003035Cobalt[tungsten carbide co-treated with Cobalt] results in decreased expression of LYZ mRNA18078969
D005576Colforsin3-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone inhibits the reaction [Colforsin results in increased secretion of LYZ protein]15234967
D005576ColforsinColforsin results in decreased secretion of LYZ protein15194485
D005576ColforsinColforsin results in increased secretion of LYZ protein15234967
D005576Colforsin[Thapsigargin co-treated with Colforsin] results in increased secretion of LYZ protein15234967
D056831Coordination ComplexesCoordination Complexes binds to LYZ protein21429825
D003300CopperCopper binds to LYZ protein17154358
D003300Copper[triazacyclononane analog co-treated with Copper] binds to LYZ protein21429825
D019327Copper SulfateCopper Sulfate results in decreased expression of LYZ mRNA19549813
D003345CorticosteroneCorticosterone results in increased expression of LYZ mRNA21715713
D003474CurcuminCurcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of LYZ mRNA]18200517
D016572CyclosporineCyclosporine results in decreased expression of LYZ mRNA25562108|2798913
D003561CytarabineCytarabine results in increased expression of LYZ mRNA19194470
C014347decitabinedecitabine results in decreased methylation of LYZ gene17000900
C014347decitabine[decitabine results in decreased methylation of LYZ gene] which results in increased expression of LYZ mRNA17000900|1700090
C014347decitabinedecitabine results in increased expression of LYZ mRNA19194470
D002945CisplatinCisplatin results in increased expression of LYZ mRNA27594783
D004052Diethylnitrosamine[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of LYZ mRNA28943392
D004054Diethylstilbestrol[Diethylstilbestrol co-treated with Progesterone] results in increased expression of LYZ mRNA21715713
D004054DiethylstilbestrolDiethylstilbestrol results in increased expression of LYZ mRNA21715713
D002117CalcitriolCalcitriol results in increased expression of LYZ mRNA16847355|2648566
D004997Ethinyl EstradiolEthinyl Estradiol results in increased expression of LYZ mRNA15834898|1735126
D005034Ethylmercuric ChlorideEthylmercuric Chloride binds to LYZ protein18524619
D009240N-Formylmethionine Leucyl-PhenylalanineN-Formylmethionine Leucyl-Phenylalanine results in increased secretion of LYZ protein9545557
C056507gemcitabinegemcitabine results in decreased expression of LYZ mRNA17039268
D005839GentamicinsGentamicins results in increased expression of LYZ mRNA22061828
D005905GlyburideGlyburide results in decreased secretion of LYZ protein15234967
D005905GlyburideGlyburide results in increased secretion of LYZ protein15194485
C010974glyphosateglyphosate affects the expression of LYZ mRNA25434756
D006418HemeHeme analog results in increased secretion of LYZ protein23355332
D006418HemeSB 203580 inhibits the reaction [Heme analog results in increased secretion of LYZ protein]23355332
D017313FenretinideFenretinide results in decreased expression of LYZ mRNA28973697
D006861Hydrogen PeroxideLYZ protein results in decreased susceptibility to Hydrogen Peroxide16317028
C410337K 7174K 7174 results in decreased expression of LYZ mRNA24086573
C008261lead acetatelead acetate results in decreased activity of LYZ protein22581110
C029891lead chloridelead chloride results in decreased expression of LYZ protein24419708
C482199lipopolysaccharide, E coli O55-B5"lipopolysaccharide, E coli O55-B5 results in decreased expression of LYZ mRNA"24972896
D008627Mercuric ChlorideMercuric Chloride affects the expression of LYZ mRNA20353558
C014055methyl iodidemethyl iodide results in increased methylation of LYZ protein10981816
C004925methylmercuric chloridemethylmercuric chloride binds to LYZ protein18524619
C500085muraglitazarmuraglitazar results in decreased expression of LYZ mRNA21515302
D009532NickelNickel results in increased expression of LYZ mRNA25583101
C558013NSC 689534NSC 689534 results in increased expression of LYZ mRNA20971185
C024713n-tetradecanen-tetradecane results in decreased expression of LYZ protein17337753
C508075Pam(3)CSK(4) peptide[bis(4-hydroxyphenyl)sulfone co-treated with Pam(3)CSK(4) peptide] results in increased activity of LYZ protein28806546
C508075Pam(3)CSK(4) peptide[bisphenol A co-treated with Pam(3)CSK(4) peptide] results in increased activity of LYZ protein28806546
C508075Pam(3)CSK(4) peptide[Pam(3)CSK(4) peptide co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of LYZ mRNA28806546
C508075Pam(3)CSK(4) peptide[Pam(3)CSK(4) peptide co-treated with bisphenol A] results in increased expression of LYZ mRNA28806546
C508075Pam(3)CSK(4) peptidePam(3)CSK(4) peptide results in increased activity of LYZ protein28806546
D010269Paraquat[HSF-1 protein co-treated with LYZ protein co-treated with AAKG-2 protein co-treated with UCP2 protein] results in decreased susceptibility to Paraquat22737090
D010269Paraquat[HSF-1 protein co-treated with LYZ protein co-treated with AAKG-2 protein] results in decreased susceptibility to Paraquat22737090
D010269Paraquat[HSF-1 protein co-treated with LYZ protein] results in decreased susceptibility to Paraquat22737090
D010269Paraquat[UCP2 protein co-treated with AAKG-2 protein co-treated with LYZ protein] results in decreased susceptibility to Paraquat22737090
D010269ParaquatLYZ protein results in decreased susceptibility to Paraquat16317028
C002669parthenolide"[parthenolide co-treated with artemisinine co-treated with Quercetin] inhibits the reaction [15-hydroxy-5,8,11,13-eicosatetraenoic acid results in increased secretion of LYZ protein]"23355332
C002669parthenolide"parthenolide inhibits the reaction [15-hydroxy-5,8,11,13-eicosatetraenoic acid results in increased secretion of LYZ protein]"23355332
C101814perfluoro-n-undecanoic acidperfluoro-n-undecanoic acid results in decreased expression of LYZ mRNA23602845
C023036perfluorooctanoic acidperfluorooctanoic acid binds to LYZ protein14599586
C006253pirinixic acidpirinixic acid results in decreased expression of LYZ mRNA19162173
D011070Poly I-C[Poly I-C co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of LYZ mRNA28806546
D011070Poly I-C[Poly I-C co-treated with bisphenol A] results in increased expression of LYZ mRNA28806546
C009007potassium persulfatepotassium persulfate results in increased expression of LYZ protein20815409
D011285Pregnenolone CarbonitrilePregnenolone Carbonitrile results in decreased expression of LYZ mRNA19162173
D011374Progesterone[Diethylstilbestrol co-treated with Progesterone] results in increased expression of LYZ mRNA21715713
D011374ProgesteroneProgesterone results in increased expression of LYZ mRNA21715713
D011374Progesterone[Estradiol co-treated with Progesterone] results in decreased expression of LYZ mRNA20660070
D011374ProgesteroneProgesterone affects the expression of LYZ mRNA17251523
C010313pseudocumenepseudocumene results in decreased expression of LYZ protein17337753
D011794Quercetin"Quercetin inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased degradation of LYZ protein]"11322927
D011794Quercetin"[parthenolide co-treated with artemisinine co-treated with Quercetin] inhibits the reaction [15-hydroxy-5,8,11,13-eicosatetraenoic acid results in increased secretion of LYZ protein]"23355332
D011794Quercetin"Quercetin inhibits the reaction [15-hydroxy-5,8,11,13-eicosatetraenoic acid results in increased secretion of LYZ protein]"23355332
D011794QuercetinQuercetin results in decreased expression of LYZ mRNA21632981
C059514resveratrolresveratrol results in decreased expression of LYZ mRNA19228061
C089730rosiglitazonerosiglitazone results in decreased expression of LYZ mRNA21515302
C093642SB 203580"SB 203580 inhibits the reaction [15-hydroxy-5,8,11,13-eicosatetraenoic acid results in increased secretion of LYZ protein]"23355332
C093642SB 203580SB 203580 inhibits the reaction [Heme analog results in increased secretion of LYZ protein]23355332
C016104sodium bichromate[Benzo(a)pyrene co-treated with sodium bichromate] results in decreased expression of LYZ mRNA21632023
C016104sodium bichromate[Benzo(a)pyrene co-treated with sodium bichromate] results in increased expression of LYZ mRNA21632023
D013311StreptozocinStreptozocin results in increased expression of LYZ mRNA16684804
D013311Streptozocinvanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of LYZ mRNA]16684804
C501413tesaglitazartesaglitazar results in decreased expression of LYZ mRNA21515302
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of LYZ mRNA27618130
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of LYZ mRNA21998131
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of LYZ mRNA21570461
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of LYZ mRNA19692669
D019284Thapsigargin[Thapsigargin co-treated with Colforsin] results in increased secretion of LYZ protein15234967
D019284ThapsigarginThapsigargin results in increased secretion of LYZ protein15234967
D013853Thioacetamide[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of LYZ mRNA28943392
D014028Tobacco Smoke PollutionTobacco Smoke Pollution results in increased expression of LYZ mRNA25447457
D014212TretinoinTretinoin results in decreased expression of LYZ mRNA15894607
C482777triazacyclononane[triazacyclononane analog co-treated with Copper] binds to LYZ protein21429825
C012589trichostatin Atrichostatin A results in increased expression of LYZ mRNA17000900
D014302Trinitrobenzenesulfonic AcidCurcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of LYZ mRNA]18200517
D014302Trinitrobenzenesulfonic AcidTrinitrobenzenesulfonic Acid results in increased expression of LYZ mRNA17982090|1820051
C080938tris(2-carboxyethyl)phosphinetris(2-carboxyethyl)phosphine results in increased reduction of LYZ protein18524619
C057693troglitazonetroglitazone results in increased expression of LYZ mRNA28973697
C057693troglitazonetroglitazone results in decreased expression of LYZ mRNA21515302
C002802tungsten carbide[tungsten carbide co-treated with Cobalt] results in decreased expression of LYZ mRNA18078969
D014635Valproic AcidValproic Acid results in decreased expression of LYZ mRNA29154799
C034028vanadyl sulfatevanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of LYZ mRNA]16684804
C025643vinclozolinvinclozolin affects the expression of LYZ mRNA19015723
D015032ZincZinc binds to LYZ protein17154358

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0003796lysozyme activity-TAS2829884  
GO:0042802identical protein binding-IPI23353684  
GO ID GO Term Qualifier Evidence PubMed
GO:0001895retina homeostasis-HEP23580065  
GO:0006954inflammatory response-TAS366724  
GO:0019730antimicrobial humoral response-TAS-  
GO:0019835cytolysis-IEA-  
GO:0031640killing of cells of other organism-IDA9727055  
GO:0042742defense response to bacterium-IDA21093056  
GO:0043312neutrophil degranulation-TAS-  
GO:0044267cellular protein metabolic process-TAS-  
GO:0050829defense response to Gram-negative bacterium-IBA21873635  
GO:0050830defense response to Gram-positive bacterium-IBA21873635  
GO:0050830defense response to Gram-positive bacterium-IDA21093056  
GO ID GO Term Qualifier Evidence PubMed
GO:0005576extracellular region-TAS-  
GO:0005615extracellular space-HDA16502470  22664934  23580065  
GO:0005615extracellular space-IDA21805676  
GO:0005615extracellular space-TAS2829884  
GO:0035578azurophil granule lumen-TAS-  
GO:0035580specific granule lumen-TAS-  
GO:0070062extracellular exosome-HDA19056867  19199708  23533145  
GO:1904724tertiary granule lumen-TAS-  
KEGG ID KEGG Term
hsa04970Salivary secretion
Reactome ID Reactome Term Evidence
R-HSA-168249Innate Immune SystemTAS
R-HSA-168256Immune SystemTAS
R-HSA-392499Metabolism of proteinsTAS
R-HSA-6798695Neutrophil degranulationTAS
R-HSA-6803157Antimicrobial peptidesTAS
R-HSA-977225Amyloid fiber formationTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
28542447Exploratory plasma proteomic analysis in a randomized crossover trial of aspirin among healthy men and women. (2017)Wang XPLoS One